SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001689375-24-000040
Filing Date
2024-07-16
Accepted
2024-07-16 16:42:17
Documents
1
Period of Report
2024-07-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1721162529.html 4  
1 FORM 4 wk-form4_1721162529.xml 4 5214
  Complete submission text file 0001689375-24-000040.txt   6788
Mailing Address C/O AMICUS THERAPEUTICS 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address
Doshi Dipal (Reporting) CIK: 0001613084 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40969 | Film No.: 241120116

Mailing Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210
Business Address ONE DESIGN CENTER PLACE SUITE 17-500 BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Issuer) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)